3B BLACKBIO DX
|
|
| BOM : 532067     NSE : 3BBLACKBIO     | |
| LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued] Debt : Low |
Updated: |
| ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward Pledged Shares : None or < 25% |
Jun 05,2026 |
|
Price(EOD): ₹ 1,121.05
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Medical Equipment/Supplies/Accessories |
| MCap: ₹ 964.10 Cr | |
| Industry Peers & Returns | 1W | 1M | 1Y |
| 3B BLACKBIO DX | 1.4% | -14.8% | -31.8% |
| LENSKART SOLUTIONS | -2.5% | 0.6% | NA |
| POLY MEDICURE | 6.3% | -14.3% | -37.8% |
| LAXMI DENTAL | -0.2% | 7.1% | -40.3% |
| PREVEST DENPRO | -1% | -10.1% | -21.2% |
| NURECA | -1.4% | -16.9% | -9.1% |
FUNDAMENTAL ANALYSIS OF 3B BLACKBIO DX
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF 3B BLACKBIO DX
 | Ratio | Consolidated | |
|---|---|---|
|
P/E P/B P/S |
16.05
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 59.93 Cr
[Latest Qtr - Mar2026 - Consolidated Results ] 3.55
P/B Calculated based on Book Value of Rs 271.00 Cr
[Latest Year - Mar2026 - Consolidated Results ] 6.78
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 141.92 Cr
[Latest Qtr - Mar2026 - Consolidated Results ] |
|
| Financial Ratios → | ||
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
100% 16% 14% |
SHARE PRICE MOMENTUM OF 3B BLACKBIO DX
3B BLACKBIO DX vs SENSEX
DEBT OF 3B BLACKBIO DX
| Year | Debt/Equity ratio | |
|---|---|---|
| Standalone | Consolidated | |
|
2025 2024 2023 Avg_3yrs |
0 0 0.08 0.03 |
0 0 0.01 - |
|
[Last Annual Data : Mar2025]
|
||
| Financial Ratios → | ||
PLEDGED PROMOTER SHARES OF 3B BLACKBIO DX
| Pledged Promoter Shares |
0 % | |
|---|---|---|
| As on : Mar2026 | ||
If less than 25% | Good |
|
| If between 25% and 50% | Neutral | |
| If greater than 50% | Bad | |
| Shareholding Pattern → | ||
QTRLY RESULTS OF 3B BLACKBIO DX
| Consolidated | Q-o-Q | Y-o-Y |
|---|---|---|
|
Revenue Op Profit Profit Before Tax Profit After Tax |
-29.62% -60.89% -45.43% -56.31% |
57.52% 7.23% 16.81% 22.03% |
| QtrlyTrend |
0 | |
| Latest Qtr: Mar2026 | ||
| Quarterly Result Analysis → | ||
3B BLACKBIO DX related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE HEALTHCARE | 0.2% | 3.5% | 9.8% |
You may also like the below Video Courses
FAQ about 3B BLACKBIO DX
Is 3B BLACKBIO DX good for long term investment?
As on Jun 05,2026, the Fundamentals of 3B BLACKBIO DX look Strong and hence it may be good for long term investment! See Financial Performance of 3B BLACKBIO DX . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is 3B BLACKBIO DX UnderValued or OverValued?
As on Jun 05,2026, 3B BLACKBIO DX is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of 3B BLACKBIO DX ?
As on Jun 05,2026, the Intrinsic Value of 3B BLACKBIO DX is Rs. 963.36 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 559.47
Fair Value [Median EV / Sales Model] : Rs. 963.36
Fair Value [Median Price / Sales Model] : Rs. 985.14
Estimated Median Fair Value of 3B BLACKBIO DX : Rs. 963.36
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
Is 3B BLACKBIO DX trading at a Premium or Discount?
As on Jun 05,2026, 3B BLACKBIO DX is trading at a Premium of 16% based on the estimates of Median Intrinsic Value!LENSKART SOLUTIONS LTD vs POLY MEDICURE LTD vs 3B BLACKBIO DX LTD